Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Small Cell Lung Cancer: Biology Advances
Christine L. Hann
School of Medicine
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Small Cell Lung Cancer: Biology Advances'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Small Cell Lung Cancer
100%
Lung Cancer Biology
100%
Duration of Response
40%
Immune Checkpoint Inhibitors
40%
Lung Cancer
20%
Poor Prognosis
20%
Response Rate
20%
Molecular Subtypes
20%
Initial Treatment
20%
Etoposide
20%
Objective Response Rate
20%
Median Overall Survival
20%
Aggressive Tumor
20%
Transcriptional Regulator
20%
Relative Expression
20%
Metastatic Behavior
20%
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
20%
Early Metastatic
20%
Platinum Agents
20%
Lung Cancer Model
20%
Triplet Regimen
20%
Therapeutic Vulnerability
20%
FDA Approval
20%
Personalized Therapeutics
20%
Set-based
20%
Medicine and Dentistry
Small Cell Lung Cancer
100%
Cancer Pathobiology
100%
Immune Checkpoint Inhibitor
33%
Malignant Neoplasm
16%
Lung Cancer
16%
Cancer Model
16%
Etoposide
16%
Overall Survival
16%
Diseases
16%
Platinum
16%
Pharmacology, Toxicology and Pharmaceutical Science
Small Cell Lung Cancer
100%
Immune Checkpoint Inhibitor
33%
Malignant Neoplasm
16%
Lung Cancer
16%
Overall Survival
16%
Etoposide
16%
Cancer Model
16%
Diseases
16%
Platinum
16%
Biochemistry, Genetics and Molecular Biology
Immune Checkpoint Inhibitor
100%
Overall Survival
50%
Cancer Model
50%